Papers
3
Total Citations
76
H-Index
3
About
Luc Dirix is a leading voice in the critical evaluation of surgical innovation, with a primary research focus on the cost-effectiveness and clinical justification of robotic-assisted surgery, particularly in gynecological oncology. His most influential work, the 2011 paper "Are Costs of Robot-Assisted Surgery Warranted for Gynecological Procedures?" (50 citations), challenges the prevailing narrative of technological adoption by arguing that the exponential rise of robotic surgery is driven more by manufacturer marketing, patient demand, and surgeon enthusiasm than by evidence-based clinical superiority. Dirix’s analysis consistently demonstrates that robot-assisted procedures are significantly more expensive than traditional video-laparoscopy, often without commensurate improvements in patient outcomes. He further explores these themes in his 2011 companion piece "Do Costs of Robotic Surgery Matter?" (13 citations), which traces the historical trajectory of robotics from industrial applications to the operating room. Dirix’s work has been instrumental in prompting surgeons and hospital administrators to question whether the high costs of robotic platforms are truly justified, making him a key figure in the ongoing debate about value-based healthcare and the responsible integration of expensive technologies into surgical practice.
Research Focus
Key Achievements
Top Papers
- 1Are Costs of Robot-Assisted Surgery Warranted for Gynecological Procedures?50 citations · 2011
- 2
- 3Do Costs of Robotic Surgery Matter?13 citations · 2011